Letters
Coeliac disease serology
Targeting coeliac disease serology
BMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e8120 (Published 10 December 2012) Cite this as: BMJ 2012;345:e8120- David J Unsworth, consultant immunologist1,
- Francis J Smith, biomedical scientist2,
- Robert J Lock, consultant clinical scientist1
- 1Department of Immunology and Immunogenetics, Southmead Hospital, North Bristol NHS Trust, Bristol BS10 5NB, UK
- 2Department of Immunology, Gloucester Royal Hospital, Gloucestershire Hospitals NHS Foundation Trust, Gloucester, UK
- joe.unsworth{at}nbt.nhs.uk
We agree that testing first degree relatives of patients with coeliac disease (CD) for gluten enteropathy is worthwhile but caution against less targeted testing, especially in patients with non-specific symptoms.1
The prevalence of CD in England is estimated at 1.0-1.2%.2 3 Prevalence is higher in “at risk” groups: 5-6% in first degree relatives and 6% in people with type …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.